KRT88P and cancer: All cancer patients should be tested for Hepatitis B Virus (HBV) before starting any systemic oncological therapy by 3 tests (hepatitis B surface antigen [HBsAg], hepatitis B core antibody [anti-HBc], and antibody to hepatitis B surface antigen).